Navigation Links
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
Date:3/27/2009

vivo before reintroduction into the body, tend to loose certain capabilities required for effective binding and retention within injured heart tissue such as that occurring after a heart attack. We believe that the effectiveness of these stem cells can be substantially improved through a targeting mechanism that involves the binding of the CXC chemokine receptor 4 (found on these stem cells in the bone marrow but reduced after ex vivo expansion) with the stromal-derived factor-1 alpha ligand that is expressed in ischemic heart tissue following a heart attack. This suggests that treatment of mesenchymal stem cells ex vivo with an Ad5IGF-1 biologic, such as Cardium's Corgentin product candidate, will lead to local production of insulin-like growth factor-1 protein to enhance this process and amplify the delivery and retention of stem cells within injured heart tissue. The recently-published research findings from the University of Cincinnati provide independent support of this possible mechanism of action and underscore the potential use of Cardium's Corgentin candidate in stem cell therapies aimed at the treatment of heart attack and other indications," stated Cardium's Chief Scientific Officer, Gabor M. Rubanyi, M.D., Ph.D.

"Cardium has been developing a portfolio of innovative DNA-based growth factor therapeutics for cardiovascular and related applications. Our Corgentin (Ad5IGF-1) product candidate is designed to lessen tissue injury and promote myocardial repair and restoration following a heart attack," noted Christopher J. Reinhard, Cardium's Chief Executive Officer. "The well-documented biological properties of IGF-1 protein include the inhibition of programmed cell death or apoptosis, adaptive cardiomyocyte hypertrophy, proliferation of cardiac progenitor cells and angiogenesis. These observations provide a strong scientific rationale for the clinical development of an IGF-1 based therapy.

"This new study pr
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
5. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
6. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
7. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
8. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
9. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
10. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
11. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. 20, ... bring cutting-edge next-generation sequencing and proteomic diagnostics and ... announced a collaboration with TESARO, Inc.  Paradigm will ... tissue samples from clinical trials to better predict ... TESARO,s TSR-011.  This may lead to more successful clinical ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
(Date:8/20/2014)... 2014  Quantum Materials Corporation (OTCQB:QTMM) today announced ... families from Bayer Technology Services GmbH, the global technological ... of Leverkusen, Germany . ... property protection for advances Quantum Materials ... manufacturing. In addition, the Bayer patents cover volume ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Ticket Down ... Championship tickets in NYC. In just a week, the ... Jean King Tennis Center. The event was originally founded in 1881 ... event, Rafael Nadal was forced to withdrawal from the event because ... 2014 women’s tournament and will return to New York City with ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... saved a group of rhesus monkeys from deadly Marburg virus, ... to 90 percent of those it infects, researchers report. ... Marburg virus, even when it was given three days after ... journal Science Translational Medicine . This is the ...
(Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
(Date:8/20/2014)... York, NY (PRWEB) August 20, 2014 ... filed on behalf of women who were allegedly injured ... move forward in New Jersey’s Bergen County Superior Court, ... Order issued on August 15, 2014, the Court has ... files for Mirena lawsuits that are part of the ...
(Date:8/20/2014)... (HealthDay News) -- Loss of brain cells that act ... seniors have trouble falling and staying asleep, a new ... be especially severe and often results in nighttime confusion ... analyzed data from the Rush Memory and Aging Project, ... 65 and are being followed until death, at which ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Pain treatments less effective for those with irritable bowel 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2
... Local residents show America how they ,Think About Their Drink, ST. LOUIS, ... prize winner of the Think About ... The Maples family entered the photo contest by submitting a ... As part of a ...
... in Bangkok, will help bring enterprise-class health information system ... ... BANGKOK, Thailand, Oct. 29 Building on a,worldwide commitment to ... software, intellectual property and,other assets from Global Care Solutions (GCS), ...
... the most devastating spinal injuries - typically those caused ... fractures of the spine are being developed and tested ... of Leeds and Queens University Belfast. The team has ... Physical Sciences Research Council (EPSRC) to develop and examine ...
... Oregon Health & Science University Cancer Institute researchers ... stomachs rather than their backs is a better method ... therapies, being able to reproduce ,the positioning of the ... , It was a surprising finding, according to according ...
... Million Americans Suffer From Food Allergies and Numbers are,Climbing; More Children ... ... of Children, Hoping to Keep Allergy From ... Doc, NEW YORK, Oct. 28 Today about 11 million ...
... safety, proper use , SUNDAY, Oct. 28 (HealthDay News) -- ... best use of household cleaners and disinfectants from the Soap ... Fact Sheet outlines the safe, proper use of surface ... linger and the types of products available for consumer and ...
Cached Medicine News:Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 2Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 3Health News:Microsoft to Acquire Innovative Healthcare Technology and Assets From Global Care Solutions 2Health News:Microsoft to Acquire Innovative Healthcare Technology and Assets From Global Care Solutions 3Health News:Engineers developing new cements to heal spinal fractures 2Health News:Positioning pelvic cancer patients on stomachs for radiation yields better results 2Health News:NEWSWEEK: Cover: Kids and the Growing Food Allergy Threat 2Health News:NEWSWEEK: Cover: Kids and the Growing Food Allergy Threat 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: